Nearmap are putting themselves in a dominant position with leading technology and their cloud based subscription marketing. The recent CR gives them the ammo to cement this dominance. If drones become cost effective you can be sure Nearmap will transition to them. I see NEA a bit like some of our biotechs such as CSL, COH or RES who are all doing fine in spite of competitors.
NEA Price at posting:
$1.64 Sentiment: Buy Disclosure: Held